Besides, the findings of this study have significant implications regarding the role of lncRNAs-mediated m6A modification in modulating HCC progression, and also indicate that the CASC11-ALKBH5-UBE2T axis may be a novel therapeutic target for HCC treatment. This evidence concerns the gene UBE2T and hepatocellular carcinoma.